IASLC
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...
Be sure to visit the podcast's website and support the creator: www.iaslc.org
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
IASLC RET NSCLC 22.02.2023 34:13
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about NSCLC with RET rearrangements, including diagnosis, treatment, and new exciting research coming down the pipeline. Podcast guests are: Dr. Justin Gainor, the Director of the Center for Thoracic Cancers at the Massachusetts General Hospital (MGH), Director of Targeted Immunotherapy in the Henri and Belinda T...
IASLC - KRAS G12C 21.02.2023 33:37
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a conversation on KRAS G12C mutation. Joining the podcast are Dr. Melissa Johnson, the Program Director of Lung Cancer Research at the Sarah Cannon Research Institute and Dr. Ferdinandos Skoulidis, an Associate Professor at the University of Texas MD Anderson Cancer Center.
IASLC - LALCA Highlights 07.02.2023 36:31
The Latin American Conference on Lung Cancer, held in Uruguay, wrapped up in late January. To provide a summary of key findings from the meeting, Lung Cancer Considered host Dr. Narjust Florez interviewed two prominent oncologists from South America: Dr. Clarissa Mathias, Dr. Mathias is a medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quali...
IASLC FDA Approval Adjuvant Pembrolizumab For NSCLC 02.02.2023 30:49
On January 26, 2023, the US FDA granted approval of pembrolizumab, an anti-PD-1 antibody, as an adjuvant therapy for patients with resected NSCLC. In this episode of Lung Cancer Considered host Dr. Stephen Liu leads a discussion on this approval with two thoracic medical oncologists with extensive expertise in this space: Dr. Jamie Chaft, an Associate Attending at Memorial Sloan Kettering Cancer C...
IASLC IPASS Study 2 25.01.2023 40:43
In this special episode of Lung Cancer Considered, hosts Dr. Stephen Liu and Dr. Narjust Florez discuss the seminal IPASS trial with its principal investigator, Dr. Tony Mok. IPASS was a randomized phase III trial that compared the EGFR TKI gefitinib to carboplatin plus paclitaxel and showed, for the first time, that in a selected population, targeted therapy was superior to chemotherapy. The init...
Lung Cancer In Brazil with Clarissa Maria Cerqueira, Mathias Ticiana Leal And Carlos G. Ferreira 24.01.2023 29:12
In a special episode of Lung Cancer Considered focusing on lung cancer in Brazil, host Dr. Clarissa Mathias, medical oncologist at Oncoclinicas Bahia and Hospital Santa Izabel, is joined by Dr. Ticiana Leal, associate professor, Department of Hematology & Oncology and director of Thoracic Medical Oncology, Winship Cancer Institute, Emory University and Dr. Carlos Gil Ferreira, president of Institu...
Patient Advocacy Groups with Janet Freeman-Daily, Seamus Cotter & Terri Conneran 17.01.2023 49:12
Host Dr. Narjust Florez engages with three leading lung cancer patient advocates on the importance of patient advocacy groups, how these were formed, challenges when managing large patient advocacy groups and the future of patient advocacy in lung cancer. Janet Freeman-Daily is a cancer patient research advocate and activist who translates the experience and science of cancer for others. She was d...
Radon with Hina Khan And Laura Mezquita 03.01.2023 33:57
Radon exposure is a known risk factor for lung cancer yet it does not garner as much attention as other risk factors. In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses radon, its impact on lung cancer diagnosis, new research covering radon and strategies to improve our patients and the general population's exposure to this radioactive gas. Her guest is Dr. Hina Khan, tho...
Radiology - Management of Lung Cancer with Florian Fintelmann and Carole Ridge 20.12.2022 36:39
Radiologists play central roles in the detection of lung cancer, in assessing response to therapy and relapse of disease and increasingly, interventional radiologists are involved with tissue sampling and lung cancer treatment. In this episode of Lung Cancer Considered, host Dr. Stephen Liu interviews two noted radiologists--Dr. Carole Ridge and Dr. Florian Fintelmann. Dr. Ridge is a consultant ra...
FDA Approval: Adagrasib with Sheena Bhalla and Joshua Sabari 16.12.2022 30:06
This week, the FDA granted accelerated approval to Adagrasib to treat advanced NSCLC with a KRAS G12C mutation after at least one prior line of systemic therapy. In this episode of Lung Cancer Considered, host Dr. Stephen Liu and two guests discuss the approval and what impact it will have on patients and clinicians. Joining the podcast are Dr. Joshua Sabari (@JSabari), assistant professor of Medi...
Lung Cancer in Israel with Alona Zer, Jair Bar and Nir Peled 16.12.2022 49:10
In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in Israel, spoken in Hebrew. Host Dr. Alona Zer, Head of the Department of Medical Oncology at the Rambam Health Care Campus, Haifa, Israel welcomes guests Dr. Jair Bar, Deputy Director, Institute of Oncology at Chaim Sheba Medical Center and Associate Professor of Oncology, School of M...
ACLC & ESMO Asia 2022 Highlights 13.12.2022 55:52
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and invited guests to discuss the IASLC Asian Conference on Lung Cancer (ACLC) held in Japan and the ESMO Asia meeting held in Singapore. Guests include Dr. James Yang, director and Professor of the Graduate Institute of Oncology at the National Taiwan University and the director of the Department of Oncology at the National Taiwan Un...
Lung Cancer in the Middle East with Nagla Karim, Houssein Abdul Sater, and Abdelrahman Mohamed 12.12.2022 31:42
In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in the Middle East (North Africa), spoken in Arabic. Host Dr. Nagla Karim, MD, PHD, Director of the Phase I Program at the Inova Schar Cancer Institute welcomes guests Dr. Abdelrahman Mohamed, MD, Head of Thoracic Surgery, NCI at Cairo University and Dr. Houssein Abdul Sater, MD, Physic...
MET In NSCLC with Noemi Reguart and Ross Camidge 06.12.2022 46:26
This episode of Lung Cancer Considered covers a subset of patients with non-small cell lung cancer with lung cancer -- MET exon 14 skipping mutations. MET exon 14 skipping mutations occur in approximately 3 to 4% of patients with NSCLC, typically in the absence of other driver mutations. Host Dr. Narjust Florez will discuss the unique clinical issues surrounding MET exon with Dr. Ross Camidge, Dir...
EMPOWER-Lung 3 with Jordi Remon and Isabel Preeshagul 29.11.2022 40:48
This episode of Lung Cancer Considered is part of our series on FDA approvals of new lung cancer therapies. Today, host Dr. Stephen Liu discusses the EMPOWER-Lung 3 regimen of the PD-1 inhibitor cemiplimab with first-line platinum doublet chemotherapy for advanced NSCLC. This regimen was approved by the FDA on November 8, 2022. His guests are Dr. Jordi Remon, a thoracic medical oncologist who had...
The POSEIDON Trial With Tejas Patil 28.11.2022 33:16
Dr. Narjust Florez discusses the POSEIDON trial with guest Dr. Tejas Patil, assistant professor at Thoracic Oncology Research Initiative, University of Colorado Cancer Center. This Phase III study led to the recent FDA approval of Tremelimumab in combination with Durvalumab and chemotherapy as first line treatment in patients with metastatic non small-cell lung cancer (NSCLC).
Climate Change & Lung Cancer, Part 2 with Christine Berg And Roselle De Guzman 15.11.2022 40:40
There has been a steady stream of research presented that ties air pollution to an increased risk for lung cancer. To discuss this trend, Lung Cancer Considered host Dr. Narjust Florez interviews Dr. Roselle De Guzman, who is a medical oncologist and professor at the Manila Central University in the Philippines and the Chair of ASCO Asia Pacific Regional Council. Joining her is Dr. Christine D. Be...
Evolution Of Stage III NSCLC with Martin Reck and Paula Antonia Ugalde Figueroa 15.11.2022 53:58
In this episode of Lung Cancer Considered, host Dr. Stephen Liu, Director of Thoracic Oncology at Georgetown University, leads a discussion about the management of stage III NSCLC. Joining him are pulmonologist Dr. Martin Reck, Head of the Department of Thoracic Oncology and the Head of the Clinical Trials Department at the Lung Clinic Grosshansdorf and thoracic surgeon Dr. Paula Antonia Ugalde Fi...
Seminal Trial Series: ECOG 1594 08.11.2022 36:31
At the time it was published in the New England Journal of Medicine in 2002, ECOG 1594 was the first study to compare whether any of the three chemotherapy regimens used at the time was superior to cisplatin and paclitaxel in patients with advanced non–small-cell lung cancer. In this episode of Lung Cancer Considered, hosts Dr. Stephen Liu and Dr. Narjust Florez interview the ECOG 1594 clinical tr...
Lung Cancer Care In Rural US With Debora Bruno And Gabrielle Rocque 01.11.2022 43:26
Lung cancer research is often centered at large, urban academic medical centers. But what research and treatment options are available for those patients with lung cancer who live in rural areas? In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses the state of rural lung cancer care and research with Dr. Debora Bruno, a thoracic medical oncologist at Case Western in Clevel...
Lung Cancer in China - Mandarin 25.10.2022 56:46
In this special edition of Lung Cancer Considered, three esteemed oncologists and lung cancer experts explore the issues facing the medical profession in China. Host Dr. Chunxia Su, Professor of Oncology at Tongji University and Deputy Director of Medical Oncology at Shanghai Pulmonary Hospital, welcomes guests Prof. Shun Lu, Director of the Chinese Lung Cancer Association, Board Member of the Chi...
Lung Cancer in Japan with Misako Nagasaka, Tetsuya Mitsudomi and Takashi Seto 23.10.2022 52:25
In keeping with its mission to cover lung cancer from a global perspective, this episode of Lung Cancer Considered focuses on lung cancer in Japan. Host Dr. Misako Nagasaka, a Thoracic Medical Oncologist from the University of California Irvine leads a Japanese-language discussion about lung cancer in Japan with respected oncologists Dr. Tetsuya Mitsudomi and Dr. Takashi Seto. Dr. Seto is a Thorac...
Liquid Biopsy with David Gandara, Charu Aggarwal and Christian Rolfo 18.10.2022 44:29
Over the past few years, the use of liquid biopsy has improved the ability to detect biomarkers for non-small cell lung cancer. In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the current state of liquid biopsies with Dr. David Gandara, Professor of Medicine and Director of Thoracic Oncology at the University of California, Davis; Dr. Charu Aggarwal, the Lesly...
Interventional Pulmonary with Rebecca Krochmal and Daniel Sterman 11.10.2022 37:23
In this episode of Lung Cancer Considered, host Dr. Narjust Florez talks about the critical role interventional pulmonologists play on the cancer care team. Joining the discussion are Dr. Daniel Sterman, the Thomas and Suzanne Murphy Professor of Pulmonary and Critical Care Medicine at the New York University Grossman School of Medicine and Dr. Rebecca Krochmal, Assistant Professor of Medicine in...
ESMO 2022 Highlights 07.10.2022 46:16
Did you miss ESMO this year? Listen to Lung Cancer Considered host and thoracic oncologist Dr. Narjust Florez discuss the key highlights involving science and notable abstracts at the meeting with Dr. Joshua Reuss, Thoracic Medical Oncologist and Assistant Professor of Medicine at Georgetown and Dr. Giannis Mountzios, Director of the Oncology Department and Clinical Trials Unit at Henry Dunant Hos...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.